Abstract
Pirfenidone is an anti-fibrotic drug clinically used in the treatment of idiopathic pulmonary fibrosis (IPF). It's mechanism of action is still not completely known, but many of its biological effects interfere with the biology of activated fibroblasts in IPF's chronic inflammation microenvironment, and considering the phenotypical and biological similarity between these activated fibrobl…